Search Browse Earnings

NRX Pharmaceuticals, Inc. — SlamSEC

NRX Pharmaceuticals, Inc.

Nasdaq:NRXPNasdaq:NRXPW

Pharmaceutical Preparations·WILMINGTON, DE

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$0

FY 2024

Adj. EBITDA

-$27.8M

FY 2024

Net Income

-$30.1M

FY 2024

EPS (Diluted)

-$1.98

FY 2022

Stock Price

$1.73

+2.1%

2026-03-09

52W Range

$1.58 – $3.84

P/E Ratio

-0.9x

Market Cap

$48.6M

Cash

$4.6M

FY 2024

Total Debt

$4.4M

FY 2023

Net Cash

$237,377

FY 2023

Enterprise Value

$48.4M

Debt / EBITDA

0.0x

FY 2024

EV / EBITDA

-1.7x

Employees

—